Study on the intestinal microflora characteristics and TCM syndromes of patients with hepatocellular carcinoma complicated with intestinal dysfunction

Changhai Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) Patients with hepatocellular carcinoma complicated with intestinal dysfunction.
•(2) A history of hepatitis B cirrhosis.
•(3) Child-Pugh=8, ascites quantity was grade 1.
•(4) Aged 18-75, male or female, out-patient or inpatient in our department.
•(5) The course of disease is more than 6 months, and the patient has persistent abdominal discomfort or pain in the last 3 months, accompanied by at least 2 of the following characteristics:
•1.Abnormal frequency of defecation (defecation >3 times a day or <3 times a week);
•2.Abnormal fecal traits (lumpy/hard or watery stools);
•3.abnormal fecal discharge process (effort, urgency, sense of exhaustion);
•4.Mucinous stool;
•5.Gastrointestinal flatulence or abdominal distension.

•(1) The patient's Child-Pugh was C, or the BCLC stage was D.
•(2) The patient had moderate or large ascites or had upper gastrointestinal bleeding.
•(3) Used gastric acid inhibitors (proton pump inhibitors and H2 receptor antagonists), microbial agents, antibacterial drugs, metformin or non-absorbable disaccharides (such as lactilose) that affect intestinal flora, or targeted therapy drugs such as sorafenib, ramvaritinib and anlotinib within the last 4 weeks.
•(4) Patients with rheumatic immune diseases or systemic inflammation such as bacterial infection in the last 3 months.
•(5) White blood cells detected by routine stool microscopy were > 3 / high magnification field.

发起方